GRI
GRI Bio, Inc.NASDAQHealthcare$2.38+1.26%ClosedMarket Cap: $213,800
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.20
P/S
0.01
EV/EBITDA
0.66
DCF Value
$65.24
FCF Yield
-4706.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
-0.0%
Operating Margin
-41.5%
Net Margin
-41.4%
ROE
-381.7%
ROA
-138.0%
ROIC
-197.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-2.7M | $-2.7M | $-5.34 | — |
| Q4 2025 | $0.00 | -Infinity% | $-2.7M | $-2.7M | $-5.34 | — |
| FY 2025 | $0.00 | -Infinity% | $-12.0M | $-12.0M | $-121.80 | — |
| Q3 2025 | $6.3M | -0.0% | $-3.4M | $-3.4M | $-35.84 | — |
| Q2 2025 | $0.00 | -Infinity% | $-2.9M | $-2.9M | $-36.68 | — |
| Q1 2025 | $22.5M | -0.0% | $-3.1M | $-3.0M | $-162.40 | — |
| Q4 2024 | $0.00 | -Infinity% | $-2.0M | $-1.9M | $-220.08 | — |
| FY 2024 | $22.5M | -0.0% | $-8.2M | $-8.2M | $-1,545.88 | — |
| Q3 2024 | $0.00 | -Infinity% | $-2.1M | $-2.1M | $-319.76 | — |
| Q2 2024 | $0.00 | -Infinity% | $-2.3M | $-2.3M | $-1,731.80 | — |
| Q1 2024 | $0.00 | -Infinity% | $-1.9M | $-1.9M | $-2,829.12 | — |
| Q4 2023 | $0.00 | -Infinity% | $-2.0M | $-2.0M | $-19,204.08 | — |